Miller Investment Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Miller Investment Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-180,901	Closed	-$3.67M	–	101
2022 Q3	$3.67M	Hold	180,901	–	–	0.77%	23
2022 Q2	$2.81M	Hold	180,901	–	–	0.58%	25
2022 Q1	$3.46M	Hold	180,901	–	–	0.55%	27
2021 Q4	$4.58M	Hold	180,901	–	–	0.66%	19
2021 Q3	$5.92M	Buy	+180,901	New	+$6.16M	1.02%	15

Other funds holding DICE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Miller Investment Management's DICE Position: Q4 2022 in Review

Miller Investment Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q4 2022, closing a stake of 180,901 shares — an estimated $3.67M sold.

Miller Investment Management first reported a position in DICE in Q3 2021 and held it in 5 quarters. The position peaked at $5.92M in Q3 2021. 109 funds tracked by Wall St. Rank hold DICE as of Q4 2022.

Miller Investment Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Miller Investment Management sold 180,901 DICE Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $3.67M.
Miller Investment Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Miller Investment Management's DICE Therapeutics, Inc. Common Stock position peaked at $5.92M in Q3 2021.
109 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Miller Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.